Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 18.61
(-0.59%)
CNY 18.61
(-0.59%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 253.64 Million CNY | 14.4% |
| 2022 | 232.03 Million CNY | 8.56% |
| 2021 | 213.73 Million CNY | 30.85% |
| 2020 | 163.34 Million CNY | -5.45% |
| 2019 | 172.75 Million CNY | 45.14% |
| 2018 | 119.02 Million CNY | 32.77% |
| 2017 | 89.64 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 72.51 Million CNY | 20.42% |
| 2024 Q3 | 68.38 Million CNY | -4.36% |
| 2024 Q1 | 60.21 Million CNY | -28.09% |
| 2023 Q3 | 54.2 Million CNY | -20.31% |
| 2023 FY | 265.44 Million CNY | 14.4% |
| 2023 Q4 | 83.74 Million CNY | 54.49% |
| 2023 Q2 | 68.02 Million CNY | 14.37% |
| 2023 Q1 | 59.47 Million CNY | -6.73% |
| 2022 Q3 | 62.13 Million CNY | 11.95% |
| 2022 Q2 | 55.5 Million CNY | 9.61% |
| 2022 Q1 | 50.63 Million CNY | -16.81% |
| 2022 FY | 232.03 Million CNY | 8.56% |
| 2022 Q4 | 63.76 Million CNY | 2.62% |
| 2021 Q1 | 45.83 Million CNY | 2.97% |
| 2021 Q4 | 60.86 Million CNY | 13.32% |
| 2021 FY | 213.73 Million CNY | 30.85% |
| 2021 Q3 | 53.71 Million CNY | 0.71% |
| 2021 Q2 | 53.33 Million CNY | 16.36% |
| 2020 Q3 | 48.69 Million CNY | 22.97% |
| 2020 Q1 | 30.54 Million CNY | -26.86% |
| 2020 Q2 | 39.59 Million CNY | 29.64% |
| 2020 FY | 163.34 Million CNY | -5.45% |
| 2020 Q4 | 44.5 Million CNY | -8.59% |
| 2019 FY | 172.75 Million CNY | 45.14% |
| 2019 Q3 | 49.58 Million CNY | 4.32% |
| 2019 Q2 | 47.52 Million CNY | 40.27% |
| 2019 Q1 | 33.88 Million CNY | 0.0% |
| 2019 Q4 | 41.76 Million CNY | -15.77% |
| 2018 FY | 119.02 Million CNY | 32.77% |
| 2017 FY | 89.64 Million CNY | 0.0% |